Cochrane · systematic review · CD007480

Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age

Imdad, A, Ahmed, Z, Bhutta, ZA · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

Neonatal2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 3 · 42.9%Moderate 3 · 42.9%High 1 · 14.3%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age

Population: infants 1 to 6 months of age
CD007480.PUB3 (current) · 7 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality: longest
RR 1.05 [0.89, 1.25]9 studies · 21339 participantsModerate
Downgraded: imprecision
Morbidity: diarrhoea: point prevalence
RR 0.99 [0.93, 1.05]2 studies · 9891 participantsModerate
Downgraded: imprecision
Adverse effects: bulging fontanelle within 48 to 72 hours
RR 3.1 [1.89, 5.09]9 studies · 13493 participantsHigh
Adverse effects: vomiting 48 to 72 hours
RR 0.95 [0.67, 1.35]2 studies · 2187 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Adverse effects: diarrhoea 48 to 72 hours
RR 1.07 [0.82, 1.4]3 studies · 2176 participantsLow
Downgraded: imprecision
Adverse effects: fever 48 to 72 hours
RR 0.94 [0.83, 1.07]3 studies · 3187 participantsLow
Downgraded: imprecision
Vitamin A deficiency: retinol < 0.7 μmol/L
RR 0.86 [0.7, 1.06]4 studies · 1204 participantsModerate
Downgraded: imprecision

Maternal vitamin A supplementation compared to placebo for the prevention of morbidity and mortality in infants up to six weeks of age

Population: patients with the prevention of morbidity and mortality in infants up to six weeks of age
CD007480.PUB2 · 7 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality in the first year of life
Maternal vitamin A supplementation vs placebo
RR 1 [0.94, 1.06]7 studies · 96203 participantsHigh
All‐cause mortality at 1 month
Maternal vitamin A supplementation vs placebo
RR 0.98 [0.87, 1.11]2 studies · 84537 participantsModerate
Downgraded: imprecision
ARI‐related mortality in the first year of life verbal autopsy or lay reporting
Maternal vitamin A supplementation vs placebo
RR 1.59 [0.84, 2.99]2 studies · 5207 participantsVery low
Downgraded: risk of bias
Diarrhoea‐related mortality in the first year of life verbal autopsy or lay reporting
Maternal vitamin A supplementation vs placebo
RR 2.57 [0.72, 9.12]2 studies · 5207 participantsVery low
Downgraded: risk of bias
Morbidity due to acute respiratory infections11
Maternal vitamin A supplementation vs placebo
Rate ratio 0.96 [0.85, 1.08]1 study · 598 participantsVery low
Downgraded: risk of bias, imprecision
Morbidity due to diarrhoea11
Maternal vitamin A supplementation vs placebo
RR 1.1 [0.99, 1.23]1 study · 598 participantsVery low
Downgraded: risk of bias, imprecision
Adverse effects
Maternal vitamin A supplementation vs placebo
RR 0 [0, 0]2 studies · 700 participantsUngraded

Young infant vitamin A supplementation compared to placebo for the prevention of morbidity and mortality in infants six months of age or less

Population: patients with the prevention of morbidity and mortality in infants six months of age or less
CD007480.PUB2 · 7 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality in the first year of life
Young infant vitamin A supplementation vs placebo
RR 0.97 [0.83, 1.12]9 studies · 59402 participantsModerate
Downgraded: risk of bias, inconsistency
All‐cause mortality at 1 month
Young infant vitamin A supplementation vs placebo
RR 0.9 [0.75, 1.08]3 studies · 17000 participantsVery low
Downgraded: risk of bias
Diarrhoea‐related mortality in the first year of life verbal autopsy or lay reporting
Young infant vitamin A supplementation vs placebo
RR 1.01 [0.72, 1.41]7 studies · 47998 participantsLow
Downgraded: risk of bias
ARI‐related mortality in the first year of life verbal autopsy or lay reporting
Young infant vitamin A supplementation vs placebo
RR 1.12 [0.91, 1.39]7 studies · 47998 participantsModerate
Downgraded: risk of bias
Morbidity in the first year of life ‐ Diarrhoea
Young infant vitamin A supplementation vs placebo
RR 1.02 [0.99, 1.06]6 studies · 24802 participantsLow
Downgraded: risk of bias, imprecision
Morbidity in the first year of life ‐ Acute respiratory infection or respiratory difficulty
Young infant vitamin A supplementation vs placebo
RR 1.04 [0.95, 1.15]4 studies · 24019 participantsLow
Downgraded: risk of bias, imprecision
Adverse effects of vitamin A supplementation ‐ Bulging fontanelle following any dose of vitamin A
Young infant vitamin A supplementation vs placebo
RR 1.55 [1.05, 2.28]10 studies · 32978 participantsLow
Downgraded: risk of bias, inconsistency

Young infant vitamin A supplementation compared to placebo for the prevention of morbidity and mortality in infants six months of age or less

Population: patients with the prevention of morbidity and mortality in infants six months of age or less
CD007480.PUB2 · 2 questions
OutcomeEffectEvidenceStatus / GRADE
Mortality in the first year of life ‐ Neonatal vitamin A supplementation
Young infant vitamin A supplementation vs placebo
RR 0.94 [0.79, 1.12]7 studies · 38865 participantsModerate
Downgraded: risk of bias
Mortality in the first year of life ‐ Post neonatal Vitamin A supplementation
Young infant vitamin A supplementation vs placebo
RR 1.05 [0.84, 1.32]3 studies · 20537 participantsModerate
Downgraded: risk of bias